Literature DB >> 34668176

LncRNA TUG1 aggravates cardiomyocyte apoptosis and myocardial ischemia/reperfusion injury.

Dongliang Fu1, Tong Gao1, Mengru Liu1, Chunyan Li1, Haiwei Li1, Hong Jiang2, Xianlun Fu2.   

Abstract

Cardiomyocyte apoptosis is a fundamental pathogenic factor leading to myocardial ischemia/reperfusion (MI/R) injury. The long non-coding RNA (IncRNA) TUG1 regulates apoptosis in various cell types. We report here that TUG1 expression is induced in mouse heart following MI/R injury as well as in cardiomyocytes subjected to simulated ischemia/reperfusion (SI/R) in vitro. Clinically, TUG1 expression is also elevated in plasma from patients with acute myocardial infarction (AMI), which implies its potential application as a disease biomarker. Functionally, TUG1 overexpression promotes, and its knockdown reduces SI/R-induced lactate dehydrogenase (LDH) release and caspase-3 activity in cardiomyocytes in vitro, illustrating that TUG1 exacerbates SI/R-induced apoptosis. Furthermore, in vivo, TUG1 aggravates MI/R injury in a mouse model, and subsequent observations show concurrent increased apoptosis of cardiomyocytes. Hence, this study unveils a clinical relevance and functional role of TUG1 in MI/R injury, and also implicates that targeting TUG1 may have therapeutic effects in treating MI/R injury.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34668176     DOI: 10.14670/HH-18-381

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  56 in total

Review 1.  Ischemia and reperfusion--from mechanism to translation.

Authors:  Holger K Eltzschig; Tobias Eckle
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.

Authors:  Fred S Apple; Alan H B Wu; Allan S Jaffe
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

3.  TUG1/miR-421/PINK1: A potential mechanism for treating myocardial ischemia-reperfusion injury.

Authors:  Jingyi Chen; Wenqian Yu; Zhihua Ruan; Shuang Wang
Journal:  Int J Cardiol       Date:  2019-10-01       Impact factor: 4.164

4.  Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction.

Authors:  Lu Gao; Yuan Liu; Sen Guo; Rui Yao; Leiming Wu; Lili Xiao; Zheng Wang; Yuzhou Liu; Yanzhou Zhang
Journal:  Cell Physiol Biochem       Date:  2017-12-01

5.  Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway.

Authors:  Liang Cheng; Zhenxiao Jin; Rong Zhao; Kai Ren; Chao Deng; Shiqiang Yu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  LncRNA TUG1 sponges microRNA-9 to promote neurons apoptosis by up-regulated Bcl2l11 under ischemia.

Authors:  Shengcai Chen; Mengdie Wang; Hang Yang; Ling Mao; Quanwei He; Huijuan Jin; Zi-Ming Ye; Xue-Ying Luo; Yuan-Peng Xia; Bo Hu
Journal:  Biochem Biophys Res Commun       Date:  2017-02-12       Impact factor: 3.575

Review 7.  MicroRNAs in myocardial infarction.

Authors:  Reinier A Boon; Stefanie Dimmeler
Journal:  Nat Rev Cardiol       Date:  2014-12-16       Impact factor: 32.419

8.  Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations.

Authors:  Fred S Apple; Heidi E Quist; Patrick J Doyle; Angela P Otto; MaryAnn M Murakami
Journal:  Clin Chem       Date:  2003-08       Impact factor: 8.327

9.  Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors.

Authors:  David Carrick; Caroline Haig; Sam Rauhalammi; Nadeem Ahmed; Ify Mordi; Margaret McEntegart; Mark C Petrie; Hany Eteiba; Stuart Hood; Stuart Watkins; Mitchell Lindsay; Ahmed Mahrous; Ian Ford; Niko Tzemos; Naveed Sattar; Paul Welsh; Aleksandra Radjenovic; Keith G Oldroyd; Colin Berry
Journal:  Eur Heart J       Date:  2015-08-10       Impact factor: 29.983

10.  Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.

Authors:  Edward T Chouchani; Carmen Methner; Sergiy M Nadtochiy; Angela Logan; Victoria R Pell; Shujing Ding; Andrew M James; Helena M Cochemé; Johannes Reinhold; Kathryn S Lilley; Linda Partridge; Ian M Fearnley; Alan J Robinson; Richard C Hartley; Robin A J Smith; Thomas Krieg; Paul S Brookes; Michael P Murphy
Journal:  Nat Med       Date:  2013-05-26       Impact factor: 53.440

View more
  1 in total

Review 1.  Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury.

Authors:  Zhihan Chen; Jingping Wu; Sijing Li; Caijiao Liu; Yulan Ren
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.